Compare ABEO & AVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | AVBC |
|---|---|---|
| Founded | 1974 | 1869 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 278.0M |
| IPO Year | 1980 | N/A |
| Metric | ABEO | AVBC |
|---|---|---|
| Price | $5.01 | $19.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $18.20 | $18.00 |
| AVG Volume (30 Days) | ★ 1.2M | 93.2K |
| Earning Date | 03-19-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | $400,000.00 | ★ $82,122,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | N/A |
| P/E Ratio | $3.89 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.93 | $14.00 |
| 52 Week High | $7.54 | $19.95 |
| Indicator | ABEO | AVBC |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 64.26 |
| Support Level | $4.94 | $18.57 |
| Resistance Level | $5.26 | $19.95 |
| Average True Range (ATR) | 0.23 | 0.66 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 35.43 | 71.88 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.